glp-1 autoimmune disease medicines may cut clot-related risks in chronically inflamed patients Roles of glucagon-like peptide 1

The Parenteral segment dominated the market with a share of 67.45% in 2025 due to the widespread availability and clinical success of injectable GLP-1 therapies

Beyond their hypoglycemic and metabolic effects, GLP-1based therapies have demonstrated anti-inflammatory effects, with in vitro and in vivo accumulating evidence demonstrating that GLP-1 reduces levels of inflammatory markers [[30], [31], [32]]

FGF21 is a newly discovered metabolic hormone produced in multiple tissues and secreted in the fasting state and regulates metabolic responses in the pancreas, liver and adipose tissues (95)

Egler went on to practice the full spectrum of family medicine (including adult medicine, pediatrics, surgery, emergency and hospital medicine, and obstetrics and gynecology) and subsequently became an Assistant Clinical Professor of Family Medicine at USC

Tang CC, Lim J, Loo LS, Jung H, Konig M, Tham LS

The Synergy Hypothesis Others believe the magic is specifically in the combination